Tuesday 21 July 2020
BrainWaveBank Limited, an artificial intelligence (‘AI’) company focused on developing a machine learning-enabled neurocognitive platform for in-home assessment and remote monitoring of central nervous system disorders, including neurodegenerative diseases such as Alzheimer’s, and psychiatric conditions such as depression and schizophrenia, announces the closing of a £1.1m financing round
